BIBLIOGRAFIA. ANDERSON, G.D. (1998) - A mechanistic approach to antiepileptic drug interactions. Ann. Pharmacother. 32 (1998)

Transcription

1 VII. BIBLIOGRAFIA

2 148

3 BIBLIOGRAFIA ANDERSON, G.D. (1998) - A mechanistic approach to antiepileptic drug interactions. Ann. Pharmacother. 32 (1998) BENES, J. [et al.] (1999) - Anticonvulsant and Sodium Channel-Blocking Properties of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine-5-carboxamide Derivatives. J. Med. Chem. 42 (1999) BERTRAND, P.; DUBAS, F. (1990) - Épilepsies: étiologie, diagnostic, évolution, pronostic et principes du traitement. Nouv. Quest. 2:6 (1990) BESAG, F.M.C. [et al.] (1998) Carbamazepine toxicity with Lamotrigine: pharmacokinetic or pharmacodynamic interaction? Epilepsia. 39:2 (1998) BIALER, M. (1993) - Comparative pharmacokinetics of the newer antiepileptic drugs. Epilepsy Res. 24:6 (1993) BIALER, M. (2002) - New Antiepileptic Drugs Currently in Clinical Trials: Is There a Strategy in Their Development? Ther. Drug Monit. 24 (2002) BIALER, M. [et al.] (2002) - Progress report on new antiepileptic drugs : a summary of the Sixth Eilat Conference (EILAT VI). Epilepsy Res. 51 (2002) BLAISE, F.D.; BOURGEOIS, M.D. (2000) - Pharmacokinetic properties of current antiepileptic drugs: what improvements are needed? Neurology. 55: suppl. 3 (2000) S11-S16. BOROWICZ, KK. [et al.] (2000) - Low propensity of conventional antiepileptic drugs for interaction with felbamate against maximal electroshock-induced seizures in mice. J. Neural. Transm. 107 (2000) BOROWICZ, K.K. [et al.] (2002) - Effect of Gabapentin on the Anticonvulsivant Activity Of Antiepileptic Drugs against Electroconvulsions in Mice: An Isobolographic Analysis. Epilepsia. 43:Suppl. 9 (2002) VII. BIBLIOGRAFIA 149

4 BRODIE, M.J. (2001) Do we need any more antiepileptic drugs? Epilepsy Res. 45 (2001) 3-6. BURSTEIN, A.H. (1995) - Evaluation of new drugs: Lamotrigine. Pharmacotherapy. 15:2 (1995) CASTEL-BRANCO, M.M. [et al.] (2003) - Anticonvulsant profile of lamotrigine in rats following a single intraperitoneal dose. J. Veterinary Pharmacol. Ther. Aug. 26:Suppl. 1 (2003) CASTEL BRANCO, M.M. (2002) - Caracterização neurofarmacocinética da lamotrigina em ratos. Coimbra. Laboratório de Farmacologia; Faculdade de Farmácia, Universidade de Coimbra, 2003.Tese de doutoramento. CLEMENS, B.; MÉNES, A.; NAGY, Z. (2004) Objective assessment of neurotoxicity while shifting from carbamazepine to oxcarbazepine. Acta Neurol. Scand. 109 (2004) CZUCZWAR, S.J.; BOROWICZ K.K. (2002) Polytherapy in epilepsy: the experimental evidence. Epilepsy Res. 52 (2002) DALBY, N.O.; NIELSON, E.B. (1997) - Comparison of the preclinical anticonvulsant profiles of Tiagabine, Lamotrigine, Gabapentin and Vigabatrin. Epilepsy Res. 28 (1997) DE SARRO, G. [et al.] (2001) - Influence or retigabine on the anticonvulsant activity of some antiepileptic drugs against audiogenic seizures in DBA/2 mice. Nauny-Schmiedeberg s Arch. Pharmacol. 363 (2001) DECKERS, C.L.P. [et al.] (2000) - Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewd. Nov. 41:11 Epilepsia. (2000) DECKERS, C.L.P. [et al.] (2002) - Current limitations of antiepileptic drug therapy: a conference review. Epilepsy Res. 53 (2002)

5 DIAS, M.S. (1992) Epilepsia: Considerações sobre a doença e o seu tratamento. Farmácia Port.76:7/8(1992) DICHTER, M.A.; BRODIE, M.J. (1996) - Drug Therapy: New Antiepileptic drugs. N. Engl. J. Med. Jun. 334:24 (1996) DREIFUSS, F.E. (1997) - Classification of Epileptic Seizures. In ENGEL, J.; PEDLEY, T.A. ed. lit. - Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott-Raven Publishers, Raven Publishers, Vol. 1, chapter 44 (1997) ELWES, R.D.C.; BINNIE, C.D. (1996) - Clinical Pharmacokinetics of Newer Antiepileptic Drugs: Lamotrigine, Vigabatrin; Gabapentin and Oxcarbazepine. Clin. Pharmacokinet. Jun. 30:6 (1996) ENGEL, J.J.; PEDLEY, T.A. (1997) - Introduction: What is Epilepsy? In ENGEL, J.; PEDLEY,T.A. ed. lit. - Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott-Raven Publishers. Vol. 1: Chapter 1 (1997) 1-7. ESTEVES, A.; GARRETT, C. (2001) - Antiepilépicos. In OSSWALD, W.; GUIMARÃES, S. Terapêutica Medicamentosa e suas Bases Farmacológicas. 4ªed.Porto: Porto Editora, (2001) Cap.18: p FERRENDELLI, J.A. (2001) - Concerns with antiepileptic drug initiation: safety, tolerability and efficacy. Epilepsia. 42:Suppl. 4 (2001) FERRENDELLI, J.A. (1999) - Pharmacology of Antiepileptic Drug Polypharmacy. Epilepsia. 40:Suppl. 5 (1999) S81-S83. FERRENDELLI, J.A. (1995) - Relating pharmacology to clinical practice: The pharmacologic basis of rational polypharmacy. Neurology. 45: Suppl. 2 (1995) S12-S16. FILIPE, C.N. (1997) Mecanismos básicos das epilepsias. Rev Port Pedopsiq. 12 (1997) VII. BIBLIOGRAFIA 151

6 FIRMINO, H.; MARQUES, R. (1991) - Aspectos psicossociais do Doente epiléptico. Médice. 9 (1991) FITTON, A.; GOA, K.L. (1995) - Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy. Drugs. 50:4 (1995) GESSNER, P.K. (1995) - Isobolographic analysis of interactions: an update on applications and utility. Toxicology. 105 (1995) GILMAN, J.T. (1995) - Lamotrigine: an antiepileptic agent for the treatment of partial seizures. Ann. Pharmacother. 29 (1995) GIL-NAGEL, A. (2003) Review of new antiepileptic drugs as initial therapy. Epilepsia. 44 (Suppl. 4) (2003) GOA, K.L.; ROSS, S.R.; CHRISP P. (1993) - Lamotrigine: a review of its pharmacological and clinical efficacy in epilepsy. Drugs. 46:1 (1993) GOODMAN, L.S. [et al.] (1958) - Comparison of maximal seizures evoked by pentylenetetrazol (metrazol) and electroshock in mice, and their modification by anticonvulsants. J. Pharmacol. Exp. Ther. 108 (1958) GRAVES, N.M.; LEPPIK, I.E. (1991) - Antiepileptic medications in development. Ann. Pharmacother. 25 (1991) GUBERMAN, A. (1998) - Monotherapy or polytherapy for Epilepsy? Can. J. Neurol. Sci. 25:Suppl. 4 (1998) S3-S8. HACHAD, H.; RAGUENEAU-MAJLESSI, I.; LEVY, R.H. (2002) - New Antiepileptic Drugs: Review on Drug Interactions. Ther. Drug. Monit. 24:1 (2002) HULSMAN, J. A. R. J. (1995) Effects of felbamate on the pharmacokinetics of oxcarbazepine. Clin. Pharmacol. Ther. 58 (1995)

7 KALIS, M.M.; HUFF, N.A. (2001) - Oxcarbazepine, an antiepileptic agent. Clin. Ther. 23: 5 (2001) KÄLVIÄINEN, R.; KERÄNEN, T.; RIEKKINEN, SR P.J. (1993) - Place of the Newer Antiepileptic Drugs in the Tratment of epilepsy. Drugs. 46:6 (1993) KUBOVA, H.; MARES, P. (1993) - Anticonvulsant action of Oxcarbazepine, Hydroxycarbazepine, and Carbazepine against metrazol-induced motor seizures in developing rats. Epilepsia. 34:1 (1993) KWAN, P.; BRODIE, M.J. (2000) Epilepsy after the first drug fails: substitution or add-on? 9 Epilepsy Quarterly. (2000) KWAN, P. (2001) - Management of Patients with Newly Diagnosed Epilepsy. Epilepsy Quarterly. 9:2 (2001) LAFFAN, R.J.; SWINYARD, E.A.; GOODMAN, L.S. (1957) - Stimulus intensity, maximal electroshock seizures, and potency of anticonvulsants in rats. Arch. Int. Pharmacodyn. Ther. 111 (1957) LEACH, J.P. (2000) Antiepileptic drugs: safety in numbers? Seizure. 9 (2000) LEPPIK, I. E. (2000) - Monotherapy and polypharmacy. Neurology 55: Suppl. 3 (2000) S25-S29. LÖSCHER, W.; FASSBENDER, C.P,; NOLTING, B. (1991) - The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsivante drugs. II. Maximal Electroshock Seizure Models. Epilepsy Res. 8 (1991) LÖSCHER, W.; SCHMIDT, D. (1994) - Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation? Epilepsy Res. 17 (1994) LÖSCHER, W.; SCHMIDT, D. (1998) - Which animals models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 2 (1998) VII. BIBLIOGRAFIA 153

8 LÖSCHER, W. (1998) - New visions in the pharmacology of anticonvulsion. Eur. J. Pharmacol. 342 (1998) LÖSCHER, W. (2002) Current status and future directions in the pharmacotherapy of epilepsy. Trends Pharmacol. Sci. 23: 3 (2002) LÖSCHER, W,; SCHMIDT, D, (2002) New horizonts in the development of antiepileptic drugs. Epilepsy Res. 50 (2002) LOWENSTEIN, D.H. (2002) Convulsões e Epilepsia. In HARRISON,T.R..- Medicina Interna. Rio de Janeiro: Mc Graw Hill; 15ª ed., Vol II chapter 360: p LUSZCZKI, J.J. [et al.] (2003a) - Interactions Between Oxcarbazepine and Conventional Antiepileptic Drugs in the Maximal Electroshock Test in Mice: An Isobolographic Analysis. Epilepsia. 44:4 (2003a) LUSZCZKI, J.J. [et al.] (2003b) - Interactions of Lamotrigine with Topiramate and First-generation Antiepileptic Drugs in the Maximal Electroshock Test in Mice: An Isobolographic Analysis. Epilepsia. 44:8 (2003b) LUSZCZKI, J.J. [et al.] (2003c) - Interactions of Tiagabine with some antiepileptics in the maximal electroshock in mice. Pharmacol. Biochem. Behav. 75 (2003c) LUSZCZKI, J.J.; CZUCZWAR, S.J. (2003d) - Isobolographic and subthreshold methods in the detection of interactions between oxcarbazepine and conventional antiepileptics - a comparative study. Epilepsy Res. 56 (2003d) LUSZCZKI, J.J.; CZUCZWAR, S.J. (2004) - Isobolographic profile of interactions between tiagabine and gabapentin: a preclinical study. Naunyn- Schmiedeberg s Arch Pharmacol. 369 (2004) MACHADO, S.G.; ROBINSON, G.A. (1994) - A direct, general approach based on isobolograms for assessing the joint of drugs in pre-clinical experiments. Stats. Med. 13 (1994)

9 MATAR, K.M. [et al.] (1999) - Effect of valproic acid on the pharmacokinetic profile of Oxcarbazepine in the rat. Pharm. Acta Helv. 73 (1999) MAY, T.W.; KORN-MERKER, E.; RAMBECK, B. (2003) - Clinical Pharmacokinetics of Oxcarbazepine. Clin. Pharmacokinet. 42:12 (2003) MCAULEY, J. [et al.] (2002) - Newer Therapies in the Drug Treatment of Epilepsy. Ann. Pharmacother. Jan. 36 (2002) MCLEAN, M.J. (1994) - Oxcarbazepine: mechanisms of action. Epilepsia. 35: Suppl. 3 (1994) S5-S9. MILLER A.A. [et al.] (1986) - Pharmacological studies on Lamotrigine, a novel potencial antiepileptic drug: I. Anticonvulsant profile in mice and rats. Epilepsia. 27:5 (1986) MILLER, A.A. [et al.] (1986a) - Lamotrigine. In MELDRUM, B.L.; PORTER, R.J., ed. Lit. - Currents problems in epilepsy. 4-New antiepileptic drugs. London: John Libbey & Co., 1986.Chapter 12:p NATSCH, S. [et al.] (1997) - Newer Anticonvulsants Drugs: role of paharmacology, drug interactions and adverse reactions in drug choice. Drug Saf. Oct. 17:4 (1997) NOVACK, G.D.; STARK, L.G.; PETERSON,S. (1978) - Anticonvulsant effects of Bezhydryl Piperazines on Maximal Electroshock seizures in Rats. J. Pharm. Exp. Ther. 208:3 (1978) PASCHOA, O.E.D. (1997) - Seizure patterns in Kindling and Cortical Stimulation models of experimental epilepsy. Brain Res. 770 (1997) PATSALOS, P.N.; DUNCAN, J.S. (1993) - Antiepileptic Drugs: A Review of Clinically Significant Drug Interactions. Drug Saf. 9:3 (1993) PATSALOS, P.N.; SANDER, J.W.A.S. (1994) - Newer Antiepileptic Drugs: Towards an improved Risk-Benefit Ratio. Drug Saf. 11:1 (1994) VII. BIBLIOGRAFIA 155

10 PATSALOS P.N. [et al.] (2002) - The importance of drug interactions in epilepsy therapy. Epilepsia. 43:4 (2002) PELLOCK, J.M. (2000) - Treatment of Epilepsy in the New Millennium. Pharmacoterapy. 20:8 Pt. 2 (2000) 129S-138S. PERUCCA E. (2002) - Marketed new antiepileptic drugs: are they better than old-generation agents? Ther. Drug Monit. 24 (2002) PERUCCA E. (2002) Overtreatment in epilepsy: adverse consequences and mechanisms. Epilepsy Res. 52 (2002) PERUCCA E. (1995) - Pharmacological principles as a basis for polytherapy. Acta Neurol. Scand. Suppl. 162 (1995) PERUCCA E. (1996) - The New Generation Antiepileptic drugs: advantages and disadvantages. Br. J. Clin. Pharmacol. 42 (1996) Rambeck, B.; Specht, U.; Wolf, P. (1996) - Pharmacokinetic Interactions of New Antiepileptic Drugs. Clin. Pharmacokinet. Oct. 31:4 (1996) Rambeck, B.; Wolf, P. (1993) - Lamotrigine clinical pharmacokinetics. Clin. Pharmacokinet. 25:6 (1993) RATAUD, J. [et al.] (1994) - Comparative study of voltage-sensitive sodium channel blockers in focal ischaemia and electric convulsions in rodents. Neuros. Letters. 172 (1994) RIVA, R. [et al.] (1996) - Pharmacokinetic Interactions between Antiepileptic Drugs. Clin. Pharmacokinet. Dec. 31:6 (1996) ROKS, G. [et al.] (1999) - Effects of Polytherapy Compared With Monotherapy in Antiepileptics Drugs: An Animal Study. J. Pharmacol. Exp. Ther. 288 (1999) SABERS, A.; GRAM, L. (2000) - Newer Anticonvulsants: comparative review of drug interactions and adverse efects. Drugs. Jul. 60:1 (2000)

11 SMITH, P.E.M. (2001) Clinical recommendations for oxcarbazepine. Seizure. 10 (2001) SCHMIDT, D.; GRAM, L. (1995) Monotherapy versus Polytherapy in Epilepsy. CNS Drugs. 3:3 (1995) SCHMIDT, D. [et al.] (2001) Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view. Acta Neurol. Scand. 104 (2001) SCHMIDT, D.; ELGER, C.; HOLMES, G.L. (2002) Pharmacological overtreatment in epilepsy. Mechanisms and management. Epilepsy Res. 52 (2002a) SCHMIDT, D. (2002) Strategies to prevent overtreatment with antiepileptic drugs in patients with epilepsy. Epilepsy Res. 52 (2002b) SCHMUTZ, M. [et al.] (1994) - Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action. Epilepsia. 35 Suppl. 5 (1994) S SCHWABE, S. (1994) Oxcarbazepine: clinical development program. Epilepsia. 35: Suppl. 5 (1994) S51-S53. SCHWINGHAMMER, T. L.; KROBOTH P.D. (1988) Basic concepts in pharmacodynamic modelling. J. Clin. Pharmacol. 28 (1988) STEPHEN, L.J., BRODIE, M.J. (2002) Seizure freedom with more than one antiepileptic drug. Seizure. 11 (2002) STEINHOFF, B.J. [et al.] (2003) - The ideal characteristics of antiepileptic therapy: an overview of old and new AEDs. Acta Neurol. Scand. 107 (2003) SWIADER, M. [et al.] (2000) - Interaction of topiramate with conventional antiepileptic drugs in mice. Eur. J. Pharmacol. Jun. 30, 399:1 (2000) SWINYARD, E.A.; WOODHEAD, J.H.; WOLF, H.H. (1989) - Use of isobolograms in predicting drug interactions. In: PITLICK W, ed. VII. BIBLIOGRAFIA 157

12 Antiepileptic Drug Interactions. Bethesda, MD: National Institute of Health. (1989). SWINYARD, E.A.; KUPFERBERG, H.J. (1985) - Antiepileptic drugs: detection, quantification, and evaluation. Federation Proc. 44:10 (1985) 1-5. TALLARIDA, R.J.; RAFFA, R.B. (1996) - Testing for synergism over a range of fixed ratio drug combinations: replacing the isobologram. Life Sci. 58:2 (1996) TALLARIDA, R.J.; [et al.] (1999) Response surface analysis of synergism between morphine and clonidine. J. Pharm. Exp. Ther. 289 (1999) TALLARIDA, R.J. (2001) - Drug synergism: its detection and applications. J. Pharm. Exp. Ther. 298 (2001) TALLARIDA, R.J. (2002) - The interaction index: a measure of drug synergism. Pain. 98 (2002) TECOMA, E.S. (1999) Oxcarbazepine. Epilepsia. 40: Suppl.5 (1999) S37- S46. THOMSON, A.H.; BRODIE, M.J. (1992) - Pharmacokinetic Optimisation of Anticonvulsant Therapy. Clin. Pharmacokinet. 23:3 (1992) TOMAN, J.E.P.; SWINYARD, E.A.; GOODMAN, L.S. (1946) - Properties of maximal seizures, and their alteration by anticonvulsant drugs and other agents. J. Neurophysiol. 9 (1946) TRACY, A.; GLAUSSER, M.D. (2001) - Oxcarbazepine in the treatment of epilepsy. Pharmacoterapy. 21:8 (2001) UPTON, N. (1994) - Mechanisms of action of new antiepileptic drugs: rational design and serendipitous findings. TIPS. Dec. 15 (1994) VAN OPSTAL, J. M. [et al.] (2004) Severe overdosage with the antiepileptic drug oxcarbazepine. Br. J. Clin. Pharmacol. 58:3 (2004)

13 URE, J.A.; PERASSOLO. M.; (2000) - Update on the pathophysiology of the epilepsies - review article. J. Neurolog. Sci. 177 (2000) WAMIL, A.W. [et al.] (1994) - Effects of oxcarbazepine and 10- hydroxycarmazepine on action potencial firing and generalized seizures. Eur. J. Pharmacol. 271 (1994) WHITE, H.S. (1999) - Comparative Anticonvulsant and Mechanistic Profile of the Established and Newer Antiepileptic Drugs. Epilepsia. 40 Suppl.5 (1999) S2-S10. WHITE, H.S. (2003) - Preclinical Development of Antiepileptic Drugs: Past, Present and Future directions. Epilepsia. 44 Suppl. 7 (2003) 2-8. WOLF, P. (1997). International Classification of the Epilepsies. In ENGEL, J.; PEDLEY,T.A. ed. lit. - Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott-Raven Publishers. (1997) Vol. 1 Chapter 68: p ZONA, C. [et al.]. (2002) - Neocortical potassium corrents are enhanced by the antiepileptic drug Lamotrigine. Epilepsia. 43:7 (2002) VII. BIBLIOGRAFIA 159